Search Results - "Mansy, T."

57 Crizotinib in clinical practice: the North East of England's experience by Hall, S, Lambourne, B, Aynsley, E, Gardiner, J, Greystoke, A, Hughes, A, Jones, C, Leaning, D, Li, L, Mansy, T, Margetts, J, Mcdonald, F, Mcmenemin, R, Mulvenna, P, Peedell, C, Shakespeare, D, Simmons, T, Singhal, S, Turnbull, H

Get full text

72: Audit of outcomes of NSCLC patients treated with first line EGFR inhibitors in North East England by Margetts, J, Smith, E, Aynsley, E, Gardiner, J, Hughes, A, Jones, C, Li, L, Mansy, T, McDonald, F, McMenemin, R, Mulvenna, P, Peedell, C, Reay, E, Simmons, T, Turnbull, H

Get full text

A regional experience of advanced, non-squamous, ALK positive patients: their treatment and outcomes by Dodd, L., Li, L., Peedell, C., Aynsley, E., Mansy, T.

Get full text

LBA61 Durvalumab (durva) after sequential chemoradiotherapy (CRT) in patients (pts) with unresectable stage III NSCLC: Final analysis from PACIFIC-6 by Garassino, M.C., Mazieres, J., Reck, M., Chouaid, C., Bischoff, H., Reinmuth, N., Cove-Smith, L.S., Mansy, T., Cortinovis, D.L., Migliorino, M.R., Delmonte, A., García Sanchez, J., Chara Velarde, L.E., Bernabe Caro, R., Paz-Ares, L., Chander, P., Diaz Perez, I., Foroutanpour, K., Faivre-Finn, C.

Get full text

The experience of immunotherapy in lung cancer: an audit of immunotherapy use as second-line treatment for metastatic non-small cell lung cancer (NSCLC) in the South Tees region by Hairudin, T., Li, L., Mansy, T., Aynsley, E., Kumar, G., Masinghe, S., Peedell, C.

Get full text

The experience of immunotherapy in lung cancer: an audit of patients receiving first-line immunotherapy for metastatic small cell lung cancer in South Tees between June 2016 and December 2017 by Hairudin, T., Li, L., Mansy, T., Aynsley, E., Kumar, G., Masinghe, S., Peedell, C.

Get full text

108MO Safety and efficacy outcomes with durvalumab after sequential chemoradiotherapy (sCRT) in stage III, unresectable NSCLC (PACIFIC-6) by Garassino, M.C., Mazieres, J., Reck, M., Chouaid, C., Bischoff, H., Reinmuth, N., Cove-Smith, L., Mansy, T., Cortinovis, D., Migliorino, M.R., Delmonte, A., Garcia Sánchez, J., Chara Velarde, L.E., Bernabe, R., Paz-Ares, L., Diaz Perez, I., Trunova, N., Foroutanpour, K., Faivre-Finn, C.

Get full text

1379P Real-world (RW) clinical outcomes of patients with metastatic non-small cell lung cancer (mNSCLC) in the United Kingdom by Lester, J., Escriu, C., Khan, S., Hudson, E., Mansy, T., Conn, A., Chan, S., Powell, C., Brock, J., Conibear, J., Nelless, L., Nayar, V., Zhuo, X., Durand, A., Amin, A., Martin, P., Zhang, X., Pawar, V.

Get full text

Treatment patterns in patients with advanced non-small cell lung cancer (aNSCLC): real-world data from the United Kingdom by Lester, J., Khan, S., Powell, C., Escriu, C., Hudson, E., Conn, A., Mansy, T., Chan, S., Brock, J., Zhuo, X., Durand, A., Zhang, X., Pawar, V.

Get full text

OC-0537: Prophylactic irradiation of tracts (PIT) in patients with pleural mesothelioma: a phase III trial by Bayman, N., Appel, W., Ashcroft, L., Baldwin, D.R., Bates, A., Chappell, B., Darlison, L., Edwards, J., Ezhil, V., Gilligan, D., Hatton, M., Mansy, T., Peake, M., Pemberton, L., Rintoul, R., Ryder, W., Taylor, P., Faivre-Finn, C.

Get full text

72 - Prophylactic irradiation of tracts (PIT) in patients with pleural mesothelioma: results of a multicentre phase III trial by Bayman, N., Appel, W., Ashcroft, L., Baldwin, D.R., Bates, A.T., Darlison, L., Edwards, J.G., Ezhil, V., Gilligan, D., Hatton, M., Mansy, T., Peake, M.D., Pemberton, L., Rintoul, R.C., Ryder, W.D.J., Taylor, P., Faivre-Finn, C.

Get full text

Prophylactic irradiation of tracts (PIT) in patients with pleural mesothelioma: results of a multicentre phase III trial by Bayman, N., Appel, W., Ashcroft, L., Baldwin, D.R., Bates, A.T., Darlison, L., Edwards, J.G., Ezhil, V., Gilligan, D., Hatton, M., Mansy, T., Peake, M.D., Pemberton, L., Rintoul, R.C., Ryder, W.D.J., Taylor, P., Faivre-Finn, C.

Get full text

Planning and decommissioning of a disused Theratron- 780 teletherapy machine and the dose assessment methodology for normal and radiological emergency conditions by Mohamed M.Elsayed Breky, Muhammad S. Mansy, A.A. El-Sadek, Yousif M. Mousa, Yasser T. Mohamed

“…The present work represents a technical guideline for decommissioning a disused teletherapy machine model Theratron-780 and contains category one 60Co…”
Get full text

Bent fluorescent solar concentrators (BFSCs): Spectroscopy, stability and outdoor performance by M.G. El-Shaarawy, S.M. El-Bashir, M. Hammam, M.K. El-Mansy

“…The spectroscopic properties of a coumarin derivative dye (macrolex uorescent red G) impregnated in a poly(methylmethacrylate)/silica hybrid matrix were…”
Get full text